phage display

AbbraTech is a life science company founded in 2020 in Branford, Connecticut, by experienced life science industry researchers. Its mission is to enable discovery of antibodies against drug targets beyond the reach of conventional approaches. Its EPIVOLVE technology is a generalizable platform capable of driving antibody recognition of any exposed region of a target protein, regardless of the underlying sequence. The company works with industry and academic partners to discover next-generation medicines.

antibody discoveryantibody engineeringantibody validationB cell cloningimmunorepertoire analysis

Abwiz Bio is a fee-for-service antibody lab founded in 2012 with a PhD-led scientific team. It specializes in antibody engineering, including STEM™ staged affinity maturation and RabWiz™ rabbit immunization paired with phage display, plus antibody humanization and optimization. The company holds a patented WizAmp™ library construction method (US Pat. 9,890,414) and sells recombinant rabbit monoclonal antibodies, phospho antibodies, cell surface antibodies, and SARS-CoV-2 antibodies and proteins.

affinity maturationantibody engineeringantibody humanizationantibody optimizationcell-based phage display panninglibrary constructionrabbit immunization

Antibody Design Labs is a San Diego-based provider of phage display and antibody discovery products and services. With more than 30 years of experience, the company offers peptide and antibody phage display libraries, helper phages, phagemid and phage vectors, yeast display vectors, competent cells, and TGEX antibody expression vectors, along with services including peptide discovery, library construction, antibody discovery, engineering, reformatting, and expression.

affinity maturationantibody engineeringantibody humanizationantibody library constructionantibody reformattingimmunizationlibrary screeningmammalian cell expressionmolecular cloningpeptide library constructionphage display library constructiontransient antibody expressionyeast display

Darya Pharmaceuticals is a client-focused, U.S.-based company providing comprehensive, end-to-end preclinical radiopharmaceutical research and development services, from small molecule and peptide preparation through in vivo assays and regulatory consultation.

biodistribution and dosimetrychemistry synthesisin vitro assaysin vivo assaysnon-GLP pharm/tox studiesprotein expressionradiolabelingregulatory consultation